LSE:AZNPharmaceuticals
Is It Time To Reassess AstraZeneca (LSE:AZN) After Big Pharma Interest And DCF Upside?
If you are wondering whether AstraZeneca’s current share price offers good value or is looking stretched, it helps to break the story into returns, recent news and valuation checks.
The stock last closed at £139.16, with returns of 2.1% over 7 days, a small 0.3% decline over 30 days, 2.4% year to date and 35.7% over 1 year. The 3 year and 5 year returns sit at 25.4% and 92.2% respectively.
Recent headlines around AstraZeneca have focused on its position as a large pharmaceutical group and...